Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma. [electronic resource] by
- Amengual, Jennifer E
- Clark-Garvey, Sean
- Kalac, Matko
- Scotto, Luigi
- Marchi, Enrica
- Neylon, Ellen
- Johannet, Paul
- Wei, Ying
- Zain, Jasmine
- O'Connor, Owen A
Producer: 20131115
In:
Blood vol. 122
Availability: No items available.
|
|
9.
|
|
|
10.
|
Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma. [electronic resource] by
- Kalac, Matko
- Lue, Jennifer K
- Lichtenstein, Emily
- Turenne, Ithamar
- Rojas, Celeste
- Amengual, Jennifer E
- Sawas, Ahmed
- Deng, Changchun
- Mapara, Markus Y
- Connors, Joseph M
- Kuruvilla, John
- O'Connor, Owen A
Producer: 20190102
In:
British journal of haematology vol. 180
Availability: No items available.
|
|
11.
|
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL. [electronic resource] by
- Kalac, Matko
- Scotto, Luigi
- Marchi, Enrica
- Amengual, Jennifer
- Seshan, Venkatraman E
- Bhagat, Govind
- Ulahannan, Netha
- Leshchenko, Violetta V
- Temkin, Alexis M
- Parekh, Samir
- Tycko, Benjamin
- O'Connor, Owen A
Producer: 20120116
In:
Blood vol. 118
Availability: No items available.
|
|
12.
|
Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL). [electronic resource] by
- Xu, Xin
- Kalac, Matko
- Markson, Michael
- Chan, Mark
- Brody, Joshua D
- Bhagat, Govind
- Ang, Rosalind L
- Legarda, Diana
- Justus, Scott J
- Liu, Feng
- Li, Qingshan
- Xiong, Huabao
- Ting, Adrian T
Producer: 20210309
In:
Cell death & disease vol. 11
Availability: No items available.
|
|
13.
|
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma. [electronic resource] by
- Marchi, Enrica
- Zullo, Kelly M
- Amengual, Jennifer E
- Kalac, Matko
- Bongero, Danielle
- McIntosh, Christine M
- Fogli, Laura K
- Rossi, Maura
- Zinzani, Pier L
- Pileri, Stefano A
- Piccaluga, Pier P
- Fuligni, Fabio
- Scotto, Luigi
- O'Connor, Owen A
Publication details: British journal of haematology Oct 2015
In:
British journal of haematology vol. 171
Availability: No items available.
|
|
14.
|
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma. [electronic resource] by
- Amengual, Jennifer E
- Lichtenstein, Renee
- Lue, Jennifer
- Sawas, Ahmed
- Deng, Changchun
- Lichtenstein, Emily
- Khan, Karen
- Atkins, Laine
- Rada, Aishling
- Kim, Hye A
- Chiuzan, Codruta
- Kalac, Matko
- Marchi, Enrica
- Falchi, Lorenzo
- Francescone, Mark A
- Schwartz, Lawrence
- Cremers, Serge
- O'Connor, Owen A
Producer: 20190513
In:
Blood vol. 131
Availability: No items available.
|
|
15.
|
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial. [electronic resource] by
- O'Connor, Owen A
- Lue, Jennifer K
- Sawas, Ahmed
- Amengual, Jennifer E
- Deng, Changchun
- Kalac, Matko
- Falchi, Lorenzo
- Marchi, Enrica
- Turenne, Ithamar
- Lichtenstein, Renee
- Rojas, Celeste
- Francescone, Mark
- Schwartz, Lawrence
- Cheng, Bin
- Savage, Kerry J
- Villa, Diego
- Crump, Michael
- Prica, Anca
- Kukreti, Vishal
- Cremers, Serge
- Connors, Joseph M
- Kuruvilla, John
Producer: 20190125
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|